Skip to main content

Table 2 Known AD risk genes, core mouse phenotypes, and microbial metabolites that were used to evaluate the context-sensitive network-based prioritization algorithm

From: Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization

Evaluation dataset 1 (AD risk genes)

Evaluation dataset 2 (AD phenotypes in mouse)

Evaluation dataset 3 (AD microbial metabolites)

A2M, ABCA7, ACE, ADAM10, APBB2, APOE, APP, BLMH, HFE, MPO, MT-ND1, NOS3, PAXIP1, PLAU, PLD3, PRNP, PSEN1, PSEN2, SORL1, TF, TNF, VEGFA

Amyloid beta deposits, amyloidosis

Cerebral amyloid angiopathy

Neurofibrillary tangles

Tau protein deposits

Neurodegeneration

Neuron degeneration

Gliosis

Astrocytosis

Microgliosis

Abnormal synaptic transmission

Abnormal long-term potentiation

Abnormal long-term depression

3,4-Dihydroxybenzeneacetic acid

3-Hydroxybutyric acid

Acetylcholine

d-Glutamic acid

Dopamine

Folic acid

Gamma-aminobutyric acid

l-Lactic acid

Mannitol

Putrescine

Pyruvic acid

Succinic acid